230 related articles for article (PubMed ID: 30539019)
1. Prognostic Significance of Platelet-to-Lymphocyte Ratio in Cholangiocarcinoma: A Meta-Analysis.
Hu G; Liu Q; Ma JY; Liu CY
Biomed Res Int; 2018; 2018():7375169. PubMed ID: 30539019
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis.
Tian C; Song W; Tian X; Sun Y
Eur J Clin Invest; 2018 May; 48(5):e12917. PubMed ID: 29469190
[TBL] [Abstract][Full Text] [Related]
3. Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma.
Kitano Y; Yamashita YI; Yamamura K; Arima K; Kaida T; Miyata T; Nakagawa S; Mima K; Imai K; Hashimoto D; Chikamoto A; Baba H
Anticancer Res; 2017 Jun; 37(6):3229-3237. PubMed ID: 28551669
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract][Full Text] [Related]
5. High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin.
Huh G; Ryu JK; Chun JW; Kim JS; Park N; Cho IR; Paik WH; Lee SH; Kim YT
BMC Cancer; 2020 Sep; 20(1):907. PubMed ID: 32967632
[TBL] [Abstract][Full Text] [Related]
6. The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer: A meta-analysis.
Ma JY; Ke LC; Liu Q
Medicine (Baltimore); 2018 Oct; 97(43):e12897. PubMed ID: 30412089
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis.
Tan D; Fu Y; Su Q; Wang H
Medicine (Baltimore); 2016 Jun; 95(24):e3837. PubMed ID: 27310960
[TBL] [Abstract][Full Text] [Related]
8. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and clinicopathological significance of the platelet-to-lymphocyte ratio in melanoma: A meta-analysis involving 2099 patients.
Han SN; Feng SJ; Liu Y
Kaohsiung J Med Sci; 2021 Jan; 37(1):55-62. PubMed ID: 32783332
[TBL] [Abstract][Full Text] [Related]
10. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
11. Preoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer: A systematic review and meta-analysis.
Song W; Tian C; Wang K; Zhang RJ; Zou SB
PLoS One; 2017; 12(6):e0178762. PubMed ID: 28575033
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients.
Li W; Tao L; Lu M; Xiu D
Medicine (Baltimore); 2018 Feb; 97(8):e9616. PubMed ID: 29465553
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.
Yodying H; Matsuda A; Miyashita M; Matsumoto S; Sakurazawa N; Yamada M; Uchida E
Ann Surg Oncol; 2016 Feb; 23(2):646-54. PubMed ID: 26416715
[TBL] [Abstract][Full Text] [Related]
14. Platelet to lymphocyte ratio in biliary tract cancer: Review and meta-analysis.
Zhou LH; Luo XF
Clin Chim Acta; 2017 Nov; 474():102-107. PubMed ID: 28903023
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the prognostic role of platelet-lymphocyte ratio in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Xu H; He A; Liu A; Tong W; Cao D
Int Immunopharmacol; 2019 Dec; 77():105957. PubMed ID: 31677498
[TBL] [Abstract][Full Text] [Related]
16. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of platelet-to-lymphocyte ratio in urothelial carcinoma patients: a meta-analysis.
Bao Y; Wang Y; Li X; Pan M; Zhang H; Cheng Z; Wang X
Cancer Cell Int; 2019; 19():315. PubMed ID: 31798344
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis.
Zhang X; Zhao W; Yu Y; Qi X; Song L; Zhang C; Li G; Yang L
World J Surg Oncol; 2020 Jul; 18(1):191. PubMed ID: 32731872
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer.
Gu X; Gao XS; Cui M; Xie M; Peng C; Bai Y; Guo W; Han L; Gu X; Xiong W
Oncotarget; 2016 Aug; 7(31):49878-49887. PubMed ID: 27409665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]